Skip to main content

Spark Therapeutics, Inc. (NASDAQ: ONCE) Investor Lawsuit Against Acquisition Filed

  • Investors who purchased shares of Spark Therapeutics, Inc. (NASDAQ: ONCE) may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 5, 2019 - The case was voluntarily dismissed. March 11, 2019 - An investor, who currently holds shares of Spark Therapeutics, Inc. (NASDAQ: ONCE), filed a lawsuit against the takeover of Spark Therapeutics, Inc. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ: ONCE stockholders by agreeing to sell Spark Therapeutics, Inc. cheaply via ...



You must register (for free) or login to view the entire case.